Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156126 · ClinicalTrials.gov registry record
Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 56
- Enrollment target
NCT04156126: Completed study, sponsored by Mayo Clinic.
NCT04156126 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04156126 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
Pregnancy is a unique period which requires alterations in the immune system to allow for tolerance of a haploidentical fetus. The goal of this study is to measure maternal blood levels of proteins known to promote immune tolerance in early implantation and pregnancy to look for associations between tolerance, miscarriage and failed embryo transfer. Establishing predictive factors of miscarriage and failed in vitro fertilization could have implications for a large portion of couples and serve to guide current and future family planning efforts.
Interventions
- OTHER Blood Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2024-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156126
The ClinicalTrials.gov registry entry for NCT04156126 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Collection is the first listed.
NCT04156126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04156126 about?
NCT04156126 is a clinical study titled "Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer". Pregnancy is a unique period which requires alterations in the immune system to allow for tolerance of a haploidentical fetus. The goal of this study is to measure maternal blood levels of proteins known to promote immune tolerance in early implantation and pregnancy to look for associations between...
What is the current status of trial NCT04156126?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2019-08-23. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04156126?
The interventions under investigation include: Blood Collection (OTHER).
Who is sponsoring clinical trial NCT04156126?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.